Dr. Raja M. Flores, Chief of the Division of Thoracic Surgery at The Mount Sinai Medical Center, is a recognized leader in the field of Thoracic Surgery for his pioneering efforts in the treatment of mesothelioma. He has established VATS lobectomy, a minimally invasive approach using three small incisions, as the gold standard in the surgical treatment of lung cancer. He published two sentinel studies validating its oncological effectiveness by demonstrating equivalent survival and recurrence rates with fewer complications and shorter hospital stays when compared to standard thoracotomy. Currently, Dr. Flores is one of the most experienced VATS lobectomy surgeons in the world. He was a lead investigator in a multicenter trial of neoadjuvant alimta/cisplatin, extrapleural pneumonectomy, and high-dose radiation, which is designed to improve outcomes. He also presented this data at the 90th Annual Meeting of the American Association for Thoracic Surgery. Dr. Flores' additional research interests are based on numerous past projects relating to the multimodality management of malignant pleural mesothelioma, as well as innovative surgical techniques in minimally invasive thoracic surgery for lung cancer. He has led a number of major studies, including clinical trials of neoadjuvant gemcitabine and cisplatin followed by extrapleural pneumonectomy and high dose radiation.
http://www.youtube.com/watch?v=VJDTsng1IgI&hl=en
Recommend : netbook
0 comments:
Post a Comment